Comparison of Clinical Characteristics and Outcomes in Relapsed Versus De Novo Metastatic Non–Small Cell Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparison of Clinical Characteristics and Outcomes in Relapsed Versus De Novo Metastatic Non–Small Cell Lung Cancer

Published:2019-01 Issue:1 Volume:42 Page:75-81
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Gibson Amanda J.W.,Li Haocheng,D’Silva Adrijana,Tudor Roxana A.,Elegbede Anifat A.,Otsuka Shannon,Bebb Dafydd Gwyn,Cheung Winson Y.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference39 articles.

1. Surgical treatment of stage IV non-small cell lung cancer;Kawano;Interat Cardiovasc Thorac Surg,2012

2. Distribution and prognosis of uncommon metastases from non-small cell lung cancer;Niu;BMC Cancer,2016

3. Treatment of stage IV non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: american college of chest physicans evidence-based clinical practice guidelines;Socinski;Chest,2013

4. Systemtic chemotherapy for advanced non-small cell lung cancer: recent advances and future directions;Ramalingam;Oncologist,2008

5. Progression-free survival at 2 years is a reliable surrogate marker for the 5-year survival rate in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy;Akamatsu;BMC Cancer,2014

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase 2 study of spartalizumab (PDR001) among patients with recurrent or metastatic esophageal squamous cell carcinoma (KCSG HN18-17, K-MASTER project 12);OncoImmunology;2024-06-24

2. Comparison of survival outcomes between de novo and recurrent stage IV gastric cancers: A retrospective cohort study;Precision and Future Medicine;2023-06-30

3. Survival differences between patients with de novo and relapsed/progressed advanced non-small cell lung cancer without epidermal growth factor receptor mutations or anaplastic lymphoma kinase rearrangements;BMC Cancer;2023-05-29

4. Estimating the Impact of Delayed Access to Oncology Drugs on Patient Outcomes in Canada;Oncology and Therapy;2022-03-01

5. Comprehensive Dissection of Treatment Patterns and Outcome for Patients With Metastatic Large-Cell Neuroendocrine Lung Carcinoma;Frontiers in Oncology;2021-07-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3